ISRCTN24087468已完成不适用
Pulsed short magnetic resonance imaging (MRI) to quantify neck vascular flow changes after jugular venous dilation (venoplasty) in patients with multiple sclerosis
AIM Medical Imaging (Canada)0 个研究点目标入组 50 人开始时间: 2011年6月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Above 19 years of age
- •2. Has been diagnosed with multiple sclerosis
- •3. Has an MRI of the neck veins with flow quantification prior to having jugular venoplasty (CCSVI treatment) within the past 1 year
排除标准
- •1. Patients who have a contraindication to MRI scan
- •2. Patients with metal implants such as:
- •2.1. In the eye
- •2.2. Non-MRI compatible stents
- •2.3. Staples
研究者
相似试验
进行中（未招募）
1 期
A randomised, double-blind, placebo-controlled, multi national, Phase III study of the efficacy and safety of 300 IR sublingual immunotherapy (SLIT), starting 2 months before the grass pollen season, administered as allergen based tablets once daily to patients suffering from grass pollen rhinoconjunctivitis (with or without asthma)Estudio de fase III, aleatorizado, doble ciego, controlado con placebo, plurinacional, para investigar la eficacia y seguridad de la inmunoterapia sublingual (ITSL) 300 IR, que comienza 2 meses antes de la temporada de polinización de las gramíneas, administrada una vez al día en comprimidos a base de alérgenos a pacientes que padecen rinoconjuntivitis por alergia al polen de las gramíneas (con o sin asma)Grass pollen allergic rhinoconjunctivitisRinoconjuntivitis alérgica al polen de gramíneasMedDRA version: 9.1Level: LLTClassification code 10039085Term: Rhinitis allergicMedDRA version: 9.1Level: PTClassification code 10039085Term: Rhinitis allergicEUCTR2008-003906-32-ESStallergenes S.A.336
已完成
2 期
A randomised, double-blind, placebo-controlled, multiple-dose, dose-escalation study of the safety, tolerability, and pharmacokinetics of Lu AA24493 in patients with acute ischemic strokeischemic stroke10007963NL-OMON32595undbeck6
进行中（未招募）
不适用
A single-dose study to investigate the effects of 3 different doses of inhaled AZD2115 in COPD patientsAZD2115 is being developed to treat chronic obstructive pulmonary disease (COPD).MedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004641-41-SEAstraZeneca AB36
进行中（未招募）
不适用
A randomised, double-blind, placebo-controlled, multi national, Phase III study of the efficacy and safety of 300 IR sublingual immunotherapy (SLIT), starting 2 months before the grass pollen season, administered as allergen based tablets once daily to patients suffering from grass pollen rhinoconjunctivitis (with or without asthma)Grass pollen allergic rhinoconjunctivitisMedDRA version: 9.1Level: LLTClassification code 10039085Term: Rhinitis allergicMedDRA version: 9.1Level: PTClassification code 10039085Term: Rhinitis allergicEUCTR2008-003906-32-NLStallergenes S.A.336
进行中（未招募）
不适用
A randomised, double-blind, placebo-controlled, multi-national, multi-centre, Phase IIIpaediatric study of the efficacy and safety of 300 IR sublingual immunotherapy (SLIT)administered as allergen-based tablets once daily to children suffering from grasspollen rhinoconjunctivitisGrass Pollen RhinoconjunctivitisMedDRA version: 8.1Level: LLTClassification code 10039085Term: Rhinitis allergicEUCTR2006-003006-26-FRStallergenes S.A.350